BCLI - early access pathway for treatment of patients with amyotrophic lateral sclerosis (ALS)

Has anyone invested in this stock yet? If NurOwn® were to qualify for Health Canada’s “Notice of Compliance with Conditions” pathway, it could be authorized in Canada for distribution in early 2018.If their

Submitted March 02, 2017 at 10:53PM by dailymcoffee http://ift.tt/2m1kavO